Ocrelizumab safety update: Encouraging rates of serious infection, malignancyMay 18, 2018Multiple Sclerosis
MS drugs in Medicare Part D: Higher tiers, less coverage, more prior authorizationsApril 27, 2018Multiple Sclerosis
VIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choicesApril 24, 2018Multiple Sclerosis
Patients With MS May Not Receive Appropriate Medicines From Primary Care DoctorsApril 4, 2018Multiple Sclerosis
Extended-Interval Dosing of Natalizumab Is Associated With Reduced PML RiskApril 3, 2018Multiple Sclerosis
